Skip to main content

Table 4 Odds ratios and 95% CI for hypertension of subjects according to quartiles of baseline WHtR in the cross-sectional and cohort studies

From: Usefulness of waist-to-height ratio in screening incident hypertension among Japanese community-dwelling middle-aged and elderly individuals

  

Odds ratio (95% CI)

Waist-to-height ratio

Quartile 1

Quartile 2

Quartile 3

Quartile 4

 

Men

0.38–0.47

0.47–0.51

0.51–0.54

0.54–0.74

 

Women

0.36–0.49

0.49–0.54

0.54–0.58

0.58–0.80

 

Cross-sectional study

N = 1727

N = 432

N = 431

N = 432

N = 432

P-Value

Hypertension

 Incidence

 

202 (46.8%)

254 (58.9%)

312 (72.2%)

351 (81.3%)

< 0.001

 Non-adjusted

 

1

1.63 (1.25–2.14)

2.96 (2.23–3.93)

4.93 (3.63–6.71)

< 0.001

 Gender and age-adjusted

 

1

1.55 (1.17–2.05)

2.71 (2.02–3.63)

4.13 (3.01–5.67)

< 0.001

 Multivariate-adjusted

 

1

1.44 (1.07–1.94)

2.35 (1.71–3.22)

3.44 (2.43–4.88)

< 0.001

Cohort study

N = 419

N = 170

N = 127

N = 79

N = 43

P-Value

Hypertension

 Incidence

 

27 (15.9%)

30 (23.6%)

24 (30.4%)

14 (32.6%)

0.022

 Non-adjusted

 

1

1.64 (0.92–2.93)

2.31 (1.23–4.35)

2.56 (1.20–5.46)

0.022

 Gender and age-adjusted

 

1

1.58 (0.88–2.83)

2.13 (1.12–4.04)

2.28 (1.04–5.00)

0.064

 Multivariate-adjusted

 

1

1.54 (0.82–2.92)

2.43 (1.18–5.03)

2.52 (1.03–6.20)

0.074

  1. CI confidence interval. *Multivariate-adjusted for gender, age, smoking status, drinking status, exercise habits,presence of cardiovascular disease, triglycerides, HDL-cholesterol, LDL-cholesterol, use of antidyslipidemic medication, HbA1c, use of antidiabetic medication, eGFR, and serum uric acid. Bold values indicate significance (p < 0.05)